Home Medicine Growth Hormone, Insulin Like Growth Factor-1, and Insulin-like Growth Factor-Binding Protein-3 Levels in the Neonatal Period: A Preliminary Study
Article
Licensed
Unlicensed Requires Authentication

Growth Hormone, Insulin Like Growth Factor-1, and Insulin-like Growth Factor-Binding Protein-3 Levels in the Neonatal Period: A Preliminary Study

  • Selim Kurtoğlu , Meda Kondolot , Mümtaz M. Mazicioğlu , Nihal Hatipoğlu , Mustafa Ali Akin and Başak Akyildiz
Published/Copyright: December 22, 2010
Journal of Pediatric Endocrinology and Metabolism
From the journal Volume 23 Issue 9

ABSTRACT

Background: Growth hormone (GH), insulin-like growth factor-1 (IGF-1), and IGF-binding protein-3 (IGFBP-3) are used in the neonatal period for evaluation of diseases such as GH deficiency, intrauterine growth restriction, and hypoglycemia. However, GH level has been reported as a single value during the neonatal period. In this study, we attempted to determine the changes of GH, IGF-1, and IGFBP-3 in the neonatal period for each week.

Methods: One hundred and two appropriate-for-gestational age (AGA) term neonates who did not have any diseases that would interfere with GH-IGF axis were included in this cross-sectional study. Blood samples were collected and serum GH, IGF-1 and IGFBP-3 levels were measured by immunoradiometric analysis (IRMA) and weekly values were obtained for the first postnatal four weeks. Results: We showed that GH level [median (1st-3rd quartile)] decreases from the first to the fourth postnatal week [25.1 (18.5-37.4); 17.2 (13.2-22.8); 17.6 (12.2-20.2); 14.4 (6.60-19.8) ng/mL, respectively)], IGF-1 and IGFBP-3 levels [median (1st-3rd quartile)] increase [41.7 (18.0-70.0); 55.9 (39.0-103); 53.0 (40.0-97.7); 71.7 (44.3-137) and 1852 (1597-2451); 2430 (1645-2838); 2841 (2280-3675); 3018 (2151-4189) ng/mL, respectively)].

Conclusions: GH, IGF-1 and IGFBP-3 values can be evaluated for each week separately instead of for the entire neonatal period.


Corresponding author: Meda Kondolot,

Published Online: 2010-12-22
Published in Print: 2010-September

© Freund Publishing House Ltd.

Articles in the same Issue

  1. The Soy That Surrounds Us: An Endless Debate
  2. Soy as an Endocrine Disruptor: Cause for Caution?
  3. Mass Ascites in Mulibrey Nanism
  4. Delayed Gastric Emptying in Patients with Prader Willi Syndrome
  5. Age and Sex Differences in Fat Distribution in Non-Obese Japanese Children
  6. Premature Thelarche in Taiwanese Girls
  7. Growth Hormone, Insulin Like Growth Factor-1, and Insulin-like Growth Factor-Binding Protein-3 Levels in the Neonatal Period: A Preliminary Study
  8. Bone Maturation in 1788 Children and Adolescents with Diabetes Mellitus Type 1
  9. Serum Thyroid Hormone Levels in Preterm Infants Born before 33 Weeks of Gestation and Association of Transient Hypothyroxinemia with Postnatal Characteristics
  10. Birth Length is a Predictor of Adiponectin Levels in Japanese Young Children
  11. Genotype-Phenotype Correlation in CAH Patients with Severe CYP21A2 Point Mutations in the Republic of Macedonia
  12. Benign Transient Hyperphosphatasemia of Infancy. A Common Benign Scenario, a Big Concern for a Pediatrician
  13. Scarcity Despite Wealth: Osteopetrorickets
  14. Growth Hormone Therapy and the Risk of Tumor Recurrence after Brain Tumor Treatment in Children
  15. Insulin Resistance and the Metabolic Syndrome in Obese Children Referred to an Obesity Center
  16. Severe Dietary Protein Sensitivity and Hyperinsulinemic Hypoglycemia in a Patient with Heterozygous Mutation in HADH Gene
  17. Neonatal Autoimmune Hypothyroidism: A Patient Report
  18. Adverse Effect of Phenytoin on Glucocorticoid Replacement in a Child with Adrenal Insufficiency
  19. Investigation of Acquired Von Willebrand Syndrome in Children with Hypothyroidism: Reversal after Treatment with Thyroxine
  20. Kabuki Syndrome and Crohn Disease in a Child with Familial Hypocalciuric Hypercalcemia
Downloaded on 11.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem.2010.143/pdf
Scroll to top button